Combined	JJ
inhibition	NN
of	IN
TGFb	NN
and	CC
PDGF	NN
signaling	NN
attenuates	VBZ
radiation-induced	JJ
pulmonary	JJ
fibrosis	NN
.	.

UNASSIGNED	NNP
:	:
Background	NNP
:	:
Radiotherapy	NN
(	(
RT	NN
)	)
is	VBZ
a	DT
mainstay	NN
for	IN
the	DT
treatment	NN
of	IN
lung	NN
cancer	NN
,	,
but	CC
the	DT
effective	JJ
dose	NN
is	VBZ
often	RB
limited	VBN
by	IN
the	DT
development	NN
of	IN
radiation-induced	JJ
pneumonitis	NN
and	CC
pulmonary	JJ
fibrosis	NN
.	.

Transforming-growth-factor-b	NN
(	(
TGFb	NN
)	)
and	CC
platelet-derived	JJ
growth	NN
factor	NN
(	(
PDGF	NN
)	)
play	VBP
crucial	JJ
roles	NNS
in	IN
the	DT
development	NN
of	IN
these	DT
diseases	NNS
,	,
but	CC
the	DT
effects	NNS
of	IN
dual	JJ
growth	NN
factor	NN
inhibition	NN
on	IN
pulmonary	JJ
fibrosis	NN
development	NN
remain	VBP
unclear	JJ
.	.

Methods	NNS
:	:
C57BL/6	NN
mice	NNS
were	VBD
treated	VBN
with	IN
20	CD
Gy	NN
to	TO
the	DT
thorax	NN
to	TO
induce	VB
pulmonary	JJ
fibrosis	NN
.	.

PDGF	NN
receptor	NN
inhibitors	NNS
SU9518	NN
and	CC
SU14816	NN
(	(
imatinib	NN
)	)
and	CC
TGFb	NN
receptor	NN
inhibitor	NN
galunisertib	NN
were	VBD
applied	VBN
individually	RB
or	CC
in	IN
combinations	NNS
after	IN
RT.	NNP
.	.

Lung	NN
density	NN
and	CC
septal	JJ
fibrosis	NN
were	VBD
measured	VBN
by	IN
high-resolution	JJ
CT	NNP
and	CC
MRI	NNP
.	.

Lung	NN
histology	NN
and	CC
gene	NN
expression	NN
analyses	NNS
were	VBD
performed	VBN
and	CC
Osteopontin	NN
levels	NNS
were	VBD
studied	VBN
.	.

Results	NNS
:	:
Treatment	NN
with	IN
SU9518	NN
,	,
SU14816	NN
or	CC
galunisertib	NN
individually	RB
attenuated	VBD
radiation-induced	JJ
pulmonary	JJ
inflammation	NN
and	CC
fibrosis	NN
and	CC
decreased	VBD
radiological	JJ
and	CC
histological	JJ
signs	NNS
of	IN
lung	NN
damage	NN
.	.

Combining	VBG
PDGF	NN
and	CC
TGFb	NN
inhibitors	NNS
showed	VBD
to	TO
be	VB
feasible	JJ
and	CC
safe	JJ
in	IN
a	DT
mouse	NN
model	NN
,	,
and	CC
dual	JJ
inhibition	NN
significantly	RB
attenuated	VBD
radiation-induced	JJ
lung	NN
damage	NN
and	CC
extended	VBD
mouse	NN
survival	NN
compared	VBN
to	TO
blockage	NN
of	IN
either	CC
pathway	NN
alone	RB
.	.

Gene	NN
expression	NN
analysis	NN
of	IN
irradiated	JJ
lung	NN
tissue	NN
showed	VBD
upregulation	NN
of	IN
PDGF	NN
and	CC
TGFb-dependent	JJ
signaling	NN
components	NNS
by	IN
thoracic	JJ
irradiation	NN
,	,
and	CC
upregulation	NN
patterns	NNS
show	VBP
crosstalk	NN
between	IN
downstream	JJ
mediators	NNS
of	IN
the	DT
PDGF	NN
and	CC
TGFb	NN
pathways	NNS
.	.

Conclusion	NN
:	:
Combined	VBN
small-molecule	JJ
inhibition	NN
of	IN
PDGF	NN
and	CC
TGFb	NN
signaling	NN
is	VBZ
a	DT
safe	JJ
and	CC
effective	JJ
treatment	NN
for	IN
radiation-induced	JJ
pulmonary	JJ
inflammation	NN
and	CC
fibrosis	NN
in	IN
mice	NNS
and	CC
may	MD
offer	VB
a	DT
novel	JJ
approach	NN
for	IN
treatment	NN
of	IN
fibrotic	JJ
lung	NN
diseases	NNS
in	IN
humans	NNS
.	.

Translational	JJ
statement	NN
:	:
RT	NN
is	VBZ
an	DT
effective	JJ
treatment	NN
modality	NN
for	IN
cancer	NN
with	IN
limitations	NNS
due	JJ
to	TO
acute	JJ
and	CC
chronic	JJ
toxicities	NNS
,	,
where	WRB
TGFb	NN
and	CC
PDGF	NN
play	VBP
a	DT
key	JJ
role	NN
.	.

Here	RB
,	,
we	PRP
show	VBP
that	IN
a	DT
combined	JJ
inhibition	NN
of	IN
TGFb	NN
and	CC
PDGF	NN
signaling	NN
is	VBZ
more	RBR
effective	JJ
in	IN
attenuating	VBG
radiation-induced	JJ
lung	NN
damage	NN
compared	VBN
to	TO
blocking	VBG
either	CC
pathway	NN
alone	RB
.	.

We	PRP
used	VBD
the	DT
TGFb-receptor	NN
I	PRP
inhibitor	NN
galunisertib	NN
,	,
an	DT
effective	JJ
anticancer	JJ
compound	NN
in	IN
preclinical	JJ
models	NNS
and	CC
the	DT
PDGFR	NN
inhibitors	NNS
imatinib	NN
and	CC
SU9518	NN
,	,
a	DT
sunitinib	NN
analog	NN
.	.

Our	PRP$
signaling	NN
data	NNS
suggest	VBP
that	IN
the	DT
reduction	NN
of	IN
TGFb	NN
and	CC
PDGF	NN
signaling	NN
and	CC
the	DT
attenuation	NN
of	IN
SPP1	NN
(	(
Osteopontin	NN
)	)
expression	NN
may	MD
be	VB
responsible	JJ
for	IN
the	DT
observed	VBN
benefits	NNS
.	.

With	IN
the	DT
clinical	JJ
availability	NN
of	IN
similar	JJ
compounds	NNS
currently	RB
in	IN
phase-I/II	NN
trials	NNS
as	IN
cancer	NN
therapeutics	NNS
or	CC
already	RB
approved	VBN
for	IN
certain	JJ
cancers	NNS
or	CC
idiopathic	JJ
lung	NN
fibrosis	NN
(	(
IPF	NN
)	)
,	,
our	PRP$
study	NN
suggests	VBZ
that	IN
the	DT
combined	JJ
application	NN
of	IN
small	JJ
molecule	NN
inhibitors	NNS
of	IN
TGFb	NN
and	CC
PDGF	NN
signaling	NN
may	MD
offer	VB
a	DT
promising	JJ
approach	NN
to	TO
treat	VB
radiation-associated	JJ
toxicity	NN
in	IN
RT	NN
of	IN
lung	NN
cancer	NN
.	.

